Derivation and characterization of a dengue type 1 host range-restricted mutant virus that is attenuated and highly immunogenic in monkeys.
about
Dengue: defining protective versus pathologic immunityVaccine candidates derived from a novel infectious cDNA clone of an American genotype dengue virus type 2Fever versus fever: the role of host and vector susceptibility and interspecific competition in shaping the current and future distributions of the sylvatic cycles of dengue virus and yellow fever virusSize heterogeneity in the 3' noncoding region of South American isolates of yellow fever virusA Live, Attenuated Dengue Virus Type 1 Vaccine Candidate with a 30-Nucleotide Deletion in the 3' Untranslated Region Is Highly Attenuated and Immunogenic in MonkeysDengue virus type 3 vaccine candidates generated by introduction of deletions in the 3′ untranslated region (3′-UTR) or by exchange of the DENV-3 3′-UTR with that of DENV-4Replication-Defective Adenoviral Vaccine Vector for the Induction of Immune Responses to Dengue Virus Type 2Highly efficient production of a dengue pseudoinfectious virus.Utility, limitations, and future of non-human primates for dengue research and vaccine developmentDengue vaccine: priorities and progress.Viral kinetics of primary dengue virus infection in non-human primates: a systematic review and individual pooled analysisYellow fever vaccine.Potential of ancestral sylvatic dengue-2 viruses to re-emerge.Dengue vaccines for travelers.A chimeric dengue virus vaccine using Japanese encephalitis virus vaccine strain SA14-14-2 as backbone is immunogenic and protective against either parental virus in mice and nonhuman primates.Editorial: the challenge of dengue vaccine development and introduction.
P2860
Q24609884-86A6A27E-2223-46E1-84DC-107F6B5EE1BAQ24805308-0DB40A70-33A3-4A30-A2A2-EDFF8621F688Q26864533-B62A631B-63C9-4728-917C-80C798A3B32CQ27469453-DD2F66B1-AA9F-4E6C-B554-154255BD8CF9Q27473080-3BF132FC-2600-4887-B292-5F0AFE201366Q27485404-50D602AC-7626-4A25-9293-3C6AE9F756DEQ27487570-01F02C05-B115-4E6D-B4C0-FB8EC13AA9E0Q33852796-8AC70673-3887-4699-BCE7-756FDE4F0364Q34238916-A099FE30-6BBA-4CD0-B8DF-DBCE2C40068CQ35964754-3F35FE6B-5C3C-4AF0-B779-B411BBB9D393Q36082908-D7161FA8-79DF-48C8-AF19-9E2E2C1E67E6Q36238729-C43FEBC6-3A61-468B-833C-7D96502D3D51Q36718596-FB2A6C76-48C6-45F7-8D37-D7D5B6BE8500Q37194772-D2D63493-4052-4A83-B9F9-07A6036AAECCQ37336762-F14056BA-D435-461B-823E-253304D87E50Q42982539-1CED279F-326D-4350-8C06-77A3F80F1C2E
P2860
Derivation and characterization of a dengue type 1 host range-restricted mutant virus that is attenuated and highly immunogenic in monkeys.
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
Derivation and Characterizatio ...... Highly Immunogenic in Monkeys
@nl
Derivation and characterizatio ...... highly immunogenic in monkeys.
@ast
Derivation and characterizatio ...... highly immunogenic in monkeys.
@en
type
label
Derivation and Characterizatio ...... Highly Immunogenic in Monkeys
@nl
Derivation and characterizatio ...... highly immunogenic in monkeys.
@ast
Derivation and characterizatio ...... highly immunogenic in monkeys.
@en
prefLabel
Derivation and Characterizatio ...... Highly Immunogenic in Monkeys
@nl
Derivation and characterizatio ...... highly immunogenic in monkeys.
@ast
Derivation and characterizatio ...... highly immunogenic in monkeys.
@en
P2093
P2860
P1433
P1476
Derivation and characterizatio ...... highly immunogenic in monkeys.
@en
P2093
Barry Falgout
Estella Jones
Huo-shu Houng Hs
Lewis Markoff
Raymond Olsen
Stephanie Polo
Xiaou Pang
P2860
P304
P356
10.1128/JVI.76.7.3318-3328.2002
P577
2002-04-01T00:00:00Z